{"id":1958,"date":"2020-08-27T08:46:20","date_gmt":"2020-08-26T23:46:20","guid":{"rendered":"http:\/\/www.hcfm.jp\/journal\/?p=1958"},"modified":"2020-08-27T08:46:20","modified_gmt":"2020-08-26T23:46:20","slug":"%e7%b5%8c%e5%8f%a3%e6%8a%97%e5%87%9d%e5%9b%ba%e8%96%acppi%e5%86%85%e6%9c%8d%e4%bd%b5%e7%94%a8%e3%81%a8%e4%b8%8a%e9%83%a8%e6%b6%88%e5%8c%96%e7%ae%a1%e5%87%ba%e8%a1%80%e3%81%ab%e3%82%88%e3%82%8b","status":"publish","type":"post","link":"https:\/\/www.hcfm.jp\/journal\/?p=1958","title":{"rendered":"\u7d4c\u53e3\u6297\u51dd\u56fa\u85ac\/PPI\u5185\u670d\u4f75\u7528\u3068\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u306e\u95a2\u9023"},"content":{"rendered":"<p>\uff0d\u6587\u732e\u540d\uff0d<br \/>\nRay, Wayne A., et al. &#8220;Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding.&#8221; JAMA 320.21 (2018): 2221-2230.<\/p>\n<p>\uff0d\u8981\u7d04\uff0d<br \/>\n\u80cc\u666f\u3000\u6297\u51dd\u56fa\u85ac\u3068PPI\u306e\u4f75\u7528\u7642\u6cd5\u306f\u3001\uff08\u983b\u5ea6\u304c\u9ad8\u304f\u3001\u6642\u306b\u91cd\u7be4\u306a\u6297\u51dd\u56fa\u7642\u6cd5\u5358\u72ec\u306e\u5408\u4f75\u75c7\u3067\u3042\u308b\uff09\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306e\u30ea\u30b9\u30af\u306b\u5f71\u97ff\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\u3002<br \/>\n\u76ee\u7684 \u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u767a\u751f\u7387\u3092\u3001\u6297\u51dd\u56fa\u85ac\u5358\u72ec\u7fa4\u3068PPI\u4f75\u7528\u7fa4\u3067\u6bd4\u8f03\u3059\u308b\u3001\u307e\u305f\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u30ea\u30b9\u30af\u306b\u95a2\u4fc2\u3059\u308b\u5909\u6570\u3092\u660e\u3089\u304b\u306b\u3059\u308b<br \/>\n\u30c7\u30b6\u30a4\u30f3\u30fb\u30bb\u30c3\u30c6\u30f3\u30b0\u30fb\u5bfe\u8c61\u8005 \u904e\u53bb\u8d77\u70b9\u30b3\u30db\u30fc\u30c8\u7814\u7a76\u3002<br \/>\n2011\u5e741\u6708\uff11\u65e5\u304b\u30892015\u5e749\u670830\u65e5\u306eMedicare\u88ab\u4fdd\u967a\u8005<br \/>\n\u8981\u56e0 Apixaban\u30a8\u30ea\u30ad\u30e5\u30fc\u30b9\u3001Dabigatran\u30d7\u30e9\u30b6\u30ad\u30b5\u3001Rivaroxaban\u30a4\u30b0\u30b6\u30ec\u30eb\u30c8,Warfarin\u3068<br \/>\nPPI\u4f75\u7528\u306e\u3042\u308a\u30fb\u306a\u3057<br \/>\n\u4e3b\u305f\u308b\u30a2\u30a6\u30c8\u30ab\u30e0\u3068\u6e2c\u5b9a\u65b9\u6cd5\u3000\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u306e\u8abf\u6574\u6e08\u307f10000\u4eba\u5e74\u3042\u305f\u308a\u767a\u751f\u7387\u306810000\u4eba\u5e74\u3042\u305f\u308a\u306e\u6297\u51dd\u56fa\u85ac\u306e\u8abf\u6574\u6e08\u307f\u30ea\u30b9\u30af\u5dee\u3001\u767a\u751f\u7387\u6bd4<br \/>\n\u7d50\u679c  Table\uff12\u6dfb\u4ed8\u3042\u308a<br \/>\n1,643,123\u4eba\u306e\u5bfe\u8c61\u8005\u306b\u304a\u3044\u30661,713,183\u4ef6\u306e\u65b0\u898f\u7d4c\u53e3\u6297\u51dd\u56fa\u85ac\u306e\u30b1\u30fc\u30b9\u304c\u30b3\u30db\u30fc\u30c8\u306b\u542b\u307e\u308c\u305f\uff08\u5e73\u5747\u5e74\u9f6276.4\u6b73\u00b12.4\u3001\u3000\u5973\u6027\u306e651,427\u4eba\u5e74\u30d5\u30a9\u30ed\u30fc(\u5168\u4f53\u306e56.1%)\u3001\u5fc3\u623f\u7d30\u52d5\u306b\u3088\u308b\u5185\u670d870,330\u4eba\u5e74(74.9%)\u3001PPI\u306a\u3057\u7fa4754,389\u4eba\u5e74\u30677119\u4eba\u304c\u767a\u751f\u3002\u8abf\u6574\u6e08\u307f\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u767a\u751f\u7387115\u4eba\/\u4e00\u4e07\u4eba\u5e74\uff0895%CI:111-118\uff09\u3002Rivaroxaban\u3067\u306f1278\u4eba\u767a\u75c7\u3001\u5165\u9662\u767a\u751f\u7387144\u4eba\/\u4e00\u4e07\u4eba\u5e74\uff0895%CI:136-152\uff09\u3067\u4ed6\u306e\uff13\u5264\u3088\u308a\u3082\u7d71\u8a08\u5b66\u7684\u306b\u6709\u610f\u306b\u9ad8\u3044\u767a\u751f\u7387\u3067\u3042\u3063\u305f\u3002Apixaban\u304c279\u4eba\u767a\u75c7\u3001\u5165\u9662\u767a\u751f\u738773\u4eba\/\u4e00\u4e07\u4eba\u5e74\uff08\u767a\u751f\u7387\u6bd41.97 95%CI1.73-2.25\uff09\u3001\u30ea\u30b9\u30af\u5dee70.9\uff0895\uff05CI59.1-82.7\uff09 \u3001Dabigatran\u304c629\u4eba\u767a\u75c7\u3001\u5165\u9662\u767a\u751f\u7387120\u4eba\/\u4e00\u4e07\u4eba\u5e74\uff08\u767a\u751f\u7387\u6bd41.19 95%CI1.08-1.32\uff09\u3001\u30ea\u30b9\u30af\u5dee23.4\uff0895\uff05CI10.6-36.2\uff09\u3001Warfarin\u304c4933\u4eba\u767a\u75c7\u3001\u5165\u9662\u767a\u751f\u7387113\u4eba\/\u4e00\u4e07\u4eba\u5e74\uff08\u767a\u751f\u7387\u6bd41.27 95%CI1.19-1.35\uff09\u3001\u30ea\u30b9\u30af\u5dee30.4\uff0895\uff05CI20.3-40.6\uff09\u3067\u3042\u3063\u305f\u3002\u307e\u305fApixaban\u306f\u3001Dabigatran\uff08\u767a\u751f\u7387\u6bd40.61 95%CI0.52-0.70\uff09\u3001\u30ea\u30b9\u30af\u5dee-47.5\uff0895\uff05CI-60.6\u304b\u3089-34.3\uff09Warfarin\uff08\u767a\u751f\u7387\u6bd40.64 95%CI0.57-0.73\uff09\u3001\u30ea\u30b9\u30af\u5dee-40.5\uff0895\uff05CI-50.6\u304b\u3089-31.0\uff09\u3068\u6bd4\u8f03\u3057\u6709\u610f\u306b\u767a\u751f\u7387\u304c\u4f4e\u304b\u3063\u305f\u3002<br \/>\nPPI\u4f75\u7528\u7fa4264,447\u4eba\u5e74\uff1a76\u4eba\/\u4e00\u4e07\u4eba\u5e74\u3002PPI\u306a\u3057\u7fa4\u3068\u6bd4\u8f03\u3057\u3066\u3001\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u30ea\u30b9\u30af\u306f\u767a\u751f\u7387\u6bd40.66\uff0895%CI:0.62-0.69\uff09\u3001Apixaban\u5185\u670d\u7fa4\uff1a\u767a\u751f\u7387\u6bd40.66\uff0895%CI:0.52-0.85\uff09\u3001\u30ea\u30b9\u30af\u5dee -24 95\uff05CI-38\u304b\u3089-11\uff09\u3001Dabigatran\u5185\u670d\u7fa4\uff1a\u767a\u751f\u7387\u6bd40.49\uff0895%CI:0.41-0.59\uff09\u3001\u30ea\u30b9\u30af\u5dee -61.1 95\uff05CI-74.8\u304b\u3089-47.4\uff09\u3001Rivaroxaba\u5185\u670d\u7fa4\uff1a\u767a\u751f\u7387\u6bd40.75\uff0895%CI:0.68-0.84\uff09\u3001\u30ea\u30b9\u30af\u5dee -35.5 95\uff05CI-48.6\u304b\u3089-22.4\uff09\u3001Warfarin\u5185\u670d\u7fa4\uff1a\u767a\u751f\u7387\u6bd40.65\uff0895%CI:0.62-0.69\uff09\u3001\u30ea\u30b9\u30af\u5dee -39.3 95\uff05CI-44.5\u304b\u3089-34.2\uff09\u3068\u5168\u3066\u306b\u304a\u3044\u3066\u767a\u751f\u7387\u306f\u4f4e\u5024\u3067\u3042\u3063\u305f\u3002<br \/>\n\u7d50\u8ad6\u3000\u65b0\u898f\u306b\u7d4c\u53e3\u51dd\u56fa\u85ac\u3092\u5185\u670d\u3057\u305f\u60a3\u8005\u306b\u304a\u3044\u3066\u3001\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u767a\u751f\u7387\u306fRivaroxaba\u5185\u670d\u7fa4\u3067\u6700\u3082\u9ad8\u304f\u3001Apixaban\u5185\u670d\u7fa4\u3067\u6700\u3082\u4f4e\u304b\u3063\u305f\u3002\u305d\u308c\u305e\u308c\u306e\u6297\u51dd\u56fa\u85ac\u306b\u304a\u3044\u3066\u3001PPI\u4f75\u7528\u7fa4\u306fPPI\u306a\u3057\u7fa4\u3068\u6bd4\u3079\u3066\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u767a\u751f\u7387\u306f\u4f4e\u5024\u3067\u3042\u3063\u305f\u3002\u3053\u306e\u77e5\u898b\u306f\u3001\u6297\u51dd\u56fa\u85ac\u3092\u9078\u629e\u3059\u308b\u969b\u306e\u30ea\u30b9\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u306e\u8a55\u4fa1\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3046\u308b\u3002<\/p>\n<p><a href=\"https:\/\/www.hcfm.jp\/journal\/wp-content\/uploads\/2020\/08\/JC\u4f50\u85e4\u2460.png\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.hcfm.jp\/journal\/wp-content\/uploads\/2020\/08\/JC\u4f50\u85e4\u2460.png\" alt=\"JC\u4f50\u85e4\u2460\" width=\"863\" height=\"495\" class=\"alignnone size-full wp-image-1959\" srcset=\"https:\/\/www.hcfm.jp\/journal\/wp-content\/uploads\/2020\/08\/JC\u4f50\u85e4\u2460.png 863w, https:\/\/www.hcfm.jp\/journal\/wp-content\/uploads\/2020\/08\/JC\u4f50\u85e4\u2460-300x172.png 300w\" sizes=\"auto, (max-width: 863px) 100vw, 863px\" \/><\/a><\/p>\n<p>\u3010\u958b\u50ac\u65e5\u30112020\u5e748\u67085\u65e5\uff08\u6c34\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uff0d\u6587\u732e\u540d\uff0d Ray, Wayne A., et al. &#8220;Association of oral anticoagulants and proton pump inhibitor cotherapy with &hellip; <a href=\"https:\/\/www.hcfm.jp\/journal\/?p=1958\" class=\"more-link\">\u7d9a\u304d\u3092\u8aad\u3080 <span class=\"screen-reader-text\">\u7d4c\u53e3\u6297\u51dd\u56fa\u85ac\/PPI\u5185\u670d\u4f75\u7528\u3068\u4e0a\u90e8\u6d88\u5316\u7ba1\u51fa\u8840\u306b\u3088\u308b\u5165\u9662\u306e\u95a2\u9023<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,17],"tags":[],"class_list":["post-1958","post","type-post","status-publish","format-standard","hentry","category-22","category-17"],"_links":{"self":[{"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/posts\/1958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1958"}],"version-history":[{"count":4,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/posts\/1958\/revisions"}],"predecessor-version":[{"id":1969,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=\/wp\/v2\/posts\/1958\/revisions\/1969"}],"wp:attachment":[{"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hcfm.jp\/journal\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}